Capsid-binding retrovirus restriction factors: Discovery, restriction specificity and implications for the development of novel therapeutics

Journal of General Virology

Volumn 94, Issue PART 12, 2013, Pages 2587-2598

  Sanz Ramos, Marta ^a   Stoye, Jonathan P ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FV1 PROTEIN; GAG PROTEIN; TRIMCYPA PROTEIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHROMOSOME; DIMERIZATION; HOST; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MULTIMERIZATION; RETROVIRUS; REVIEW; TARGET CELL; VIRUS CAPSID; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS REPLICATION;

ANIMALS; CAPSID; CARRIER PROTEINS; CELL LINE; HUMANS; MICE; PROTEINS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; VIRUS REPLICATION;

EID: 84887511175     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.058180-0     Document Type: Review

References (144)

1. Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E. & Schneider, T. (2011). Evidence for the cure of HIV infection by CCR5D32/D32 stem cell transplantation. Blood 117, 2791-2799.
2. Anderson, J. L., Campbell, E. M., Wu, X., Vandegraaff, N., Engelman, A. & Hope, T. J. (2006). Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol 80, 9754-9760.
3. Balasubramaniam, M. & Freed, E. O. (2011). New insights into HIV assembly and trafficking. Physiology (Bethesda) 26, 236-251.
4. Bénit, L., De Parseval, N., Casella, J.-F., Callebaut, I., Cordonnier, A. & Heidmann, T. (1997). Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J Virol 71, 5652-5657.
5. Besnier, C., Takeuchi, Y. & Towers, G. (2002). Restriction of lentivirus in monkeys. Proc Natl Acad Sci U S A 99, 11920-11925.
6. Best, S., Le Tissier, P., Towers, G. & Stoye, J. P. (1996). Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826-829.
7. Biris, N., Yang, Y., Taylor, A. B., Tomashevski, A., Guo, M., Hart, P. J., Diaz-Griffero, F. & Ivanov, D. N. (2012). Structure of the rhesus monkey TRIM5a PRYSPRY domain, the HIV capsid recognition module. Proc Natl Acad Sci U S A 109, 13278-13283.
8. Bishop, K. N., Bock, M., Towers, G. & Stoye, J. P. (2001). Identification of the regions of Fv1 necessary for murine leukemia virus restriction. J Virol 75, 5182-5188.
9. Bishop, K. N., Mortuza, G. B., Howell, S., Yap, M. W., Stoye, J. P. & Taylor, I. A. (2006). Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1. J Virol 80, 8225-8235.
10. Black, L. R. & Aiken, C. (2010). TRIM5a disrupts the structure of assembled HIV-1 capsid complexes in vitro. J Virol 84, 6564-6569.
11. Blair, W. S., Pickford, C., Irving, S. L., Brown, D. G., Anderson, M., Bazin, R., Cao, J., Ciaramella, G., Isaacson, J. & other authors (2010). HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog 6, e1001220.
12. Boudinot, P., van der Aa, L. M., Jouneau, L., Du Pasquier, L., Pontarotti, P., Briolat, V., Benmansour, A. & Levraud, J. P. (2011). Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish. PLoS ONE 6, e22022.
13. Boutimah, F., Eekels, J. J., Liu, Y. P. & Berkhout, B. (2013). Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors. Antiviral Res 98, 121-129.
14. Brennan, G., Kozyrev, Y. & Hu, S. L. (2008). TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc Natl Acad Sci U S A 105, 3569-3574.
15. Caines, M. E., Bichel, K., Price, A. J., McEwan, W. A., Towers, G. J., Willett, B. J., Freund, S. M. & James, L. C. (2012). Diverse HIV viruses are targeted by a conformationally dynamic antiviral. Nat Struct Mol Biol 19, 411-416.
16. Campbell, E. M., Perez, O., Anderson, J. L. & Hope, T. J. (2008). Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5a. J Cell Biol 180, 549-561.
17. Chan, E., Schaller, T., Eddaoudi, A., Zhan, H., Tan, C. P., Jacobsen, M., Thrasher, A. J., Towers, G. J. & Qasim, W. (2012). Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor. Hum Gene Ther 23, 1176-1185.
18. Cohen, M. S. & Baden, L. R. (2012). Preexposure prophylaxis for HIV-where do we go from here? N Engl J Med 367, 459-461.
19. Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G. & Bieniasz, P. D. (2002). Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci U S A 99, 11914-11919.
20. Diaz-Griffero, F., Li, X., Javanbakht, H., Song, B., Welikala, S., Stremlau, M. & Sodroski, J. (2006). Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349, 300-315.
21. Diaz-Griffero, F., Qin, X. R., Hayashi, F., Kigawa, T., Finzi, A., Sarnak, Z., Lienlaf, M., Yokoyama, S. & Sodroski, J. (2009). A B-box 2 surface patch important for TRIM5a self-association, capsid binding avidity, and retrovirus restriction. J Virol 83, 10737-10751.
22. Dismuke, D. J. & Aiken, C. (2006). Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J Virol 80, 3712-3720.
23. Dodding, M. P., Bock, M., Yap, M. W. & Stoye, J. P. (2005). Capsid processing requirements for abrogation of Fv1 and Ref1 restriction. J Virol 79, 10571-10577.
24. Duran-Troise, G., Bassin, R. H., Rein, A. & Gerwin, B. I. (1977). Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell 10, 479-488.
25. Fassati, A. (2012). Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res 170, 15-24.
26. FDA (2013). US Food and Drug Administration: Antiretroviral drugs used in the treatment of HIV infection. http://www.fda.gov/ForConsumers/byAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm118915.htm.
27. Forshey, B. M., von Schwedler, U., Sundquist, W. I. & Aiken, C. (2002). Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76, 5667-5677.
28. Forshey, B. M., Shi, J. & Aiken, C. (2005). Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells. J Virol 79, 869-875.
29. Franke, E. K., Yuan, H. E. & Luban, J. (1994). Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359-362.
30. Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I. & Hill, C. P. (1996). Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285-1294.
31. Ganser-Pornillos, B. K., Cheng, A. & Yeager, M. (2007). Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 131, 70-79.
32. Ganser-Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J. G., Sundquist, W. I. & Yeager, M. (2011). Hexagonal assembly of a restricting TRIM5a protein. Proc Natl Acad Sci U S A 108, 534-539.
33. Goff, S. P. (2001). Retroviridae: the retroviruses and their replication. In Fields Virology, 4th edn, pp. 1871-1939. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
34. Goldschmidt, V., Ciuffi, A., Ortiz, M., Brawand, D., Muñ oz, M., Kaessmann, H. & Telenti, A. (2008). Antiretroviral activity of ancestral TRIM5a. J Virol 82, 2089-2096.
35. Goldstone, D. C., Yap, M. W., Robertson, L. E., Haire, L. F., Taylor, W. R., Katzourakis, A., Stoye, J. P. & Taylor, I. A. (2010). Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host Microbe 8, 248-259.
36. Goldstone, D. C., Flower, T. G., Ball, N. J., Sanz-Ramos, M., Yap, M. W., Ogrodowicz, R. W., Stanke, N., Reh, J., Lindemann, D. & other authors (2013). A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid. PLoS Pathog 9, e1003376.
37. Haran-Ghera, N., Peled, A., Brightman, B. K. & Fan, H. (1993). Lymphomagenesis in AKR. Fv-1b congenic mice. Cancer Res 53, 3433-3438.
38. Harris, R. S., Hultquist, J. F. & Evans, D. T. (2012). The restriction factors of human immunodeficiency virus. J Biol Chem 287, 40875-40883.
39. Hatziioannou, T., Cowan, S., Goff, S. P., Bieniasz, P. D. & Towers, G. J. (2003). Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 22, 385-394.
40. Hatziioannou, T., Cowan, S., Von Schwedler, U. K., Sundquist, W. I. & Bieniasz, P. D. (2004a). Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol 78, 6005-6012.
41. Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S. & Bieniasz, P. D. (2004b). Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5a. Proc Natl Acad Sci U S A 101, 10774-10779.
42. Hilditch, L., Matadeen, R., Goldstone, D. C., Rosenthal, P. B., Taylor, I. A. & Stoye, J. P. (2011). Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1. Proc Natl Acad Sci U S A 108, 5771-5776.
43. Hofmann, W., Schubert, D., La Bonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P. & Sodroski, J. (1999). Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 73, 10020-10028.
44. Hopkins, N., Schindler, J. & Hynes, R. (1977). Six NB-tropic murine leukemia viruses derived from a B-tropic virus of BALB/c have altered p30. J Virol 21, 309-318.
45. Javanbakht, H., Diaz-Griffero, F., Stremlau, M., Si, Z. & Sodroski, J. (2005). The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5a. J Biol Chem 280, 26933-26940.
46. Javanbakht, H., Yuan, W., Yeung, D. F., Song, B., Diaz-Griffero, F., Li, Y., Li, X., Stremlau, M. & Sodroski, J. (2006a). Characterization of TRIM5a trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353, 234-246.
47. Javanbakht, H., An, P., Gold, B., Petersen, D. C., O'Huigin, C., Nelson, G. W., O'Brien, S. J., Kirk, G. D., Detels, R. & other authors (2006b). Effects of human TRIM5a polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 354, 15-27.
48. Johnson, W. E. & Sawyer, S. L. (2009). Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61, 163-176.
49. Jolicoeur, P. & Baltimore, D. (1976). Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc Natl Acad Sci U S A 73, 2236-2240.
50. Jolicoeur, P. & Rassart, E. (1980). Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. J Virol 33, 183-195.
51. Jung, Y. T. & Kozak, C. A. (2000). A single amino acid change in the murine leukemia virus capsid gene responsible for the Fv1nr phenotype. J Virol 74, 5385-5387.
52. Keckesova, Z., Ylinen, L. M. & Towers, G. J. (2004). The human and African green monkey TRIM5a genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101, 10780-10785.
53. Kirmaier, A., Wu, F., Newman, R. M., Hall, L. R., Morgan, J. S., O'Connor, S., Marx, P. A., Meythaler, M., Goldstein, S. & other authors (2010). TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 8, e1000462.
54. Kono, K., Song, H., Yokoyama, M., Sato, H., Shioda, T. & Nakayama, E. E. (2010). Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5a-mediated restriction. Retrovirology 7, 72.
55. Kozak, C. A. & Chakraborti, A. (1996). Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 225, 300-305.
56. Kuroishi, A., Bozek, K., Shioda, T. & Nakayama, E. E. (2010). A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5a. Retrovirology 7, 58.
57. Kutluay, S. B., Perez-Caballero, D. & Bieniasz, P. D. (2013). Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog 9, e1003214.
58. Langelier, C. R., Sandrin, V., Eckert, D. M., Christensen, D. E., Chandrasekaran, V., Alam, S. L., Aiken, C., Olsen, J. C., Kar, A. K. & other authors (2008). Biochemical characterization of a recombinant TRIM5a protein that restricts HIV-1 replication. J Virol 82, 11682-11694.
59. Lee, K., Ambrose, Z., Martin, T. D., Oztop, I., Mulky, A., Julias, J. G., Vandegraaff, N., Baumann, J. G., Wang, R. & other authors (2010). Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7, 221-233.
60. Li, X. & Sodroski, J. (2008). The TRIM5a B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higherorder self-association. J Virol 82, 11495-11502.
61. Li, Y., Li, X., Stremlau, M., Lee, M. & Sodroski, J. (2006). Removal of arginine 332 allows human TRIM5a to bind human immunodeficiency virus capsids and to restrict infection. J Virol 80, 6738-6744.
62. Li, X., Song, B., Xiang, S. H. & Sodroski, J. (2007). Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5a. Virology 366, 234-244.
63. Li, L., Krymskaya, L., Wang, J., Henley, J., Rao, A., Cao, L. F., Tran, C. A., Torres-Coronado, M., Gardner, A. & other authors (2013a). Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther 21, 1259-1269.
64. Li, X., Kim, J., Song, B., Finzi, A., Pacheco, B. & Sodroski, J. (2013b). Virus-specific effects of TRIM5arh RING domain functions on restriction of retroviruses. J Virol 87, 7234-7245.
65. Lilly, F. (1970). Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J Natl Cancer Inst 45, 163-169.
66. Lim, S. Y., Rogers, T., Chan, T., Whitney, J. B., Kim, J., Sodroski, J. & Letvin, N. L. (2010). TRIM5a modulates immunodeficiency virus control in rhesus monkeys. PLoS Pathog 6, e1000738.
67. Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V. & Goff, S. P. (1993). Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067-1078.
68. Lukic, Z., Hausmann, S., Sebastian, S., Rucci, J., Sastri, J., Robia, S. L., Luban, J. & Campbell, E. M. (2011). TRIM5a associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 8, 93.
69. Malfavon-Borja, R., Wu, L. I., Emerman, M. & Malik, H. S. (2013). Birth, decay, and reconstruction of an ancient TRIMCyp gene fusion in primate genomes. Proc Natl Acad Sci U S A 110, E583-E592.
70. Malim, M. H. & Bieniasz, P. D. (2012). HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med 2, a006940.
71. McCarthy, K. R., Schmidt, A. G., Kirmaier, A., Wyand, A. L., Newman, R. M. & Johnson, W. E. (2013). Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5a specificity. PLoS Pathog 9, e1003352.
72. McDonald, D., Vodicka, M. A., Lucero, G., Svitkina, T. M., Borisy, G. G., Emerman, M. & Hope, T. J. (2002). Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 159, 441-452.
73. Meyerson, N. R. & Sawyer, S. L. (2011). Two-stepping through time: mammals and viruses. Trends Microbiol 19, 286-294.
74. Mische, C. C., Javanbakht, H., Song, B., Diaz-Griffero, F., Stremlau, M., Strack, B., Si, Z. & Sodroski, J. (2005). Retroviral restriction factor TRIM5a is a trimer. J Virol 79, 14446-14450.
75. Mortuza, G. B., Haire, L. F., Stevens, A., Smerdon, S. J., Stoye, J. P. & Taylor, I. A. (2004). High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431, 481-485.
76. Mortuza, G. B., Dodding, M. P., Goldstone, D. C., Haire, L. F., Stoye, J. P. & Taylor, I. A. (2008). Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation. J Mol Biol 376, 1493-1508.
77. Mü nk, C., Brandt, S. M., Lucero, G. & Landau, N. R. (2002). A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci U S A 99, 13843-13848.
78. Neagu, M. R., Ziegler, P., Pertel, T., Strambio-De-Castillia, C., Grü tter, C., Martinetti, G., Mazzucchelli, L., Grü tter, M., Manz, M. G. & Luban, J. (2009). Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest 119, 3035-3047.
79. Newman, R. M., Hall, L., Connole, M., Chen, G. L., Sato, S., Yuste, E., Diehl, W., Hunter, E., Kaur, A. & other authors (2006). Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5a. Proc Natl Acad Sci U S A 103, 19134-19139.
80. Newman, R. M., Hall, L., Kirmaier, A., Pozzi, L. A., Pery, E., Farzan, M., O'Neil, S. P. & Johnson, W. (2008). Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog 4, e1000003.
81. Nisole, S., Lynch, C., Stoye, J. P. & Yap, M. W. (2004). A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A 101, 13324-13328.
82. Nisole, S., Stoye, J. P. & Saïb, A. (2005). TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3, 799-808.
83. Nowinski, R. C. & Hays, E. F. (1978). Oncogenicity of AKR endogenous leukemia viruses. J Virol 27, 13-18.
84. Odaka, T. (1969). Inheritance of susceptibility to Friend mouse leukemia virus. V. Introduction of a gene responsible for susceptibility in the genetic complement of resistant mice. J Virol 3, 543-548.
85. Ohkura, S. & Stoye, J. P. (2013). A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5as. J Virol 87, 6455-6468.
86. Ohkura, S., Yap, M. W., Sheldon, T. & Stoye, J. P. (2006). All three variable regions of the TRIM5a B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol 80, 8554-8565.
87. Ohkura, S., Goldstone, D. C., Yap, M. W., Holden-Dye, K., Taylor, I. A. & Stoye, J. P. (2011). Novel escape mutants suggest an extensive TRIM5a binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog 7, e1002011.
88. Onyango, C. O., Leligdowicz, A., Yokoyama, M., Sato, H., Song, H., Nakayama, E. E., Shioda, T., de Silva, T., Townend, J. & other authors (2010). HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine 28 (Suppl 2), B60-B67.
89. Owens, C. M., Yang, P. C., Gö ttlinger, H. & Sodroski, J. (2003). Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J Virol 77, 726-731.
90. Owens, C. M., Song, B., Perron, M. J., Yang, P. C., Stremlau, M. & Sodroski, J. (2004). Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J Virol 78, 5423-5437.
91. Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S. & Bieniasz, P. D. (2005). Human tripartite motif 5a domains responsible for retrovirus restriction activity and specificity. J Virol 79, 8969-8978.
92. Perez-Caballero, D., Soll, S. J. & Bieniasz, P. D. (2008). Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5a proteins. PLoS Pathog 4, e1000181.
93. Perron, M. J., Stremlau, M., Song, B., Ulm, W., Mulligan, R. C. & Sodroski, J. (2004). TRIM5a mediates the postentry block to Ntropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 101, 11827-11832.
94. Perron, M. J., Stremlau, M., Lee, M., Javanbakht, H., Song, B. & Sodroski, J. (2007). The human TRIM5a restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol 81, 2138-2148.
95. Pertel, T., Hausmann, S., Morger, D., Zü ger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D. & other authors (2011). TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365.
96. Pincus, T., Hartley, J. W. & Rowe, W. P. (1971). A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med 133, 1219-1233.
97. Pincus, T., Hartley, J. W. & Rowe, W. P. (1975). A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures. Virology 65, 333-342.
98. Pryciak, P. M. & Varmus, H. E. (1992). Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J Virol 66, 5959-5966.
99. Rahm, N., Yap, M., Snoeck, J., Zoete, V., Muñ oz, M., Radespiel, U., Zimmermann, E., Michielin, O., Stoye, J. P. & other authors (2011). Unique spectrum of activity of prosimian TRIM5a against exogenous and endogenous retroviruses. J Virol 85, 4173-4183.
100. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S. & other authors (2001). The tripartite motif family identifies cell compartments. EMBO J 20, 2140-2151.
101. Reynolds, M. R., Sacha, J. B., Weiler, A. M., Borchardt, G. J., Glidden, C. E., Sheppard, N. C., Norante, F. A., Castrovinci, P. A., Harris, J. J. & other authors (2011). The TRIM5a genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge. J Virol 85, 9637-9640.
102. Rihn, S. J., Wilson, S. J., Loman, N. J., Alim, M., Bakker, S. E., Bhella, D., Gifford, R. J., Rixon, F. J. & Bieniasz, P. D. (2013). Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog 9, e1003461.
103. Rold, C. J. & Aiken, C. (2008). Proteasomal degradation of TRIM5a during retrovirus restriction. PLoS Pathog 4, e1000074.
104. Rowe, W. P. (1972). Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice. J Exp Med 136, 1272-1285.
105. Rowe, W. P. & Hartley, J. W. (1972). Studies of genetic transmission of murine leukemia virus by AKR mice. II. Crosses with Fv-1b strains of mice. J Exp Med 136, 1286-1301.
106. Sastri, J., O'Connor, C., Danielson, C. M., McRaven, M., Perez, P., Diaz-Griffero, F. & Campbell, E. M. (2010). Identification of residues within the L2 region of rhesus TRIM5a that are required for retroviral restriction and cytoplasmic body localization. Virology 405, 259-266.
107. Sawyer, S. L., Wu, L. I., Emerman, M. & Malik, H. S. (2005). Positive selection of primate TRIM5a identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 102, 2832-2837.
108. Sawyer, S. L., Wu, L. I., Akey, J. M., Emerman, M. & Malik, H. S. (2006). High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5a in humans. Curr Biol 16, 95-100.
109. Sayah, D. M., Sokolskaja, E., Berthoux, L. & Luban, J. (2004). Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573.
110. Schaller, T., Ocwieja, K. E., Rasaiyaah, J., Price, A. J., Brady, T. L., Roth, S. L., Hué, S., Fletcher, A. J., Lee, K. & other authors (2011). HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 7, e1002439.
111. Sewram, S., Singh, R., Kormuth, E., Werner, L., Mlisana, K., Karim, S. S., Ndung'u, T. & CAPRISA Acute Infection Study Team (2009). Human TRIM5a expression levels and reduced susceptibility to HIV-1 infection. J Infect Dis 199, 1657-1663.
112. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K. & Adachi, A. (1995). Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol 76, 2723-2730.
113. Short, K. M. & Cox, T. C. (2006). Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J Biol Chem 281, 8970-8980.
114. Song, B., Javanbakht, H., Perron, M., Park, D. H., Stremlau, M. & Sodroski, J. (2005a). Retrovirus restriction by TRIM5a variants from Old World and New World primates. J Virol 79, 3930-3937.
115. Song, B., Gold, B., O'Huigin, C., Javanbakht, H., Li, X., Stremlau, M., Winkler, C., Dean, M. & Sodroski, J. (2005b). The B30.2(SPRY) domain of the retroviral restriction factor TRIM5a exhibits lineagespecific length and sequence variation in primates. J Virol 79, 6111-6121.
116. Song, H., Nakayama, E. E., Yokoyama, M., Sato, H., Levy, J. A. & Shioda, T. (2007). A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5as. J Virol 81, 7280-7285.
117. Stevens, A., Bock, M., Ellis, S., Le Tissier, P., Bishop, K. N., Yap, M. W., Taylor, W. & Stoye, J. P. (2004). Retroviral capsid determinants of Fv1 NB and NR tropism. J Virol 78, 9592-9598.
118. Stoye, J. P. (2012). Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol 10, 395-406.
119. Stoye, J. P., Kaushik, N., Jeremiah, S. & Best, S. (1995). Genetic map of the region surrounding the retrovirus restriction locus, Fv1, on mouse chromosome 4. Mamm Genome 6, 31-36.
120. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. (2004). The cytoplasmic body component TRIM5a restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
121. Stremlau, M., Perron, M., Welikala, S. & Sodroski, J. (2005). Speciesspecific variation in the B30.2(SPRY) domain of TRIM5a determines the potency of human immunodeficiency virus restriction. J Virol 79, 3139-3145.
122. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I. & Sodroski, J. (2006). Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5a restriction factor. Proc Natl Acad Sci U S A 103, 5514-5519.
123. Towers, G., Bock, M., Martin, S., Takeuchi, Y., Stoye, J. P. & Danos, O. (2000). A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A 97, 12295-12299.
124. Towers, G., Collins, M. & Takeuchi, Y. (2002). Abrogation of Ref1 retrovirus restriction in human cells. J Virol 76, 2548-2550.
125. van der Straten, A., Van Damme, L., Haberer, J. E. & Bangsberg, D. R. (2012). Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS 26, F13-F19.
126. van Manen, D., Rits, M. A., Beugeling, C., van Dort, K., Schuitemaker, H. & Kootstra, N. A. (2008). The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog 4, e18.
127. Versteeg, G. A., Rajsbaum, R., Sá nchez-Aparicio, M. T., Maestre, A. M., Valdiviezo, J., Shi, M., Inn, K. S., Fernandez-Sesma, A., Jung, J. & García-Sastre, A. (2013). The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune patternrecognition receptors. Immunity 38, 384-398.
128. Virgen, C. A., Kratovac, Z., Bieniasz, P. D. & Hatziioannou, T. (2008). Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A 105, 3563-3568.
129. Voit, R. A., McMahon, M. A., Sawyer, S. L. & Porteus, M. H. (2013). Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors. Mol Ther 21, 786-795.
130. Wilson, S. J., Webb, B. L., Ylinen, L. M., Verschoor, E., Heeney, J. L. & Towers, G. J. (2008a). Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A 105, 3557-3562.
131. Wilson, S. J., Webb, B. L., Maplanka, C., Newman, R. M., Verschoor, E. J., Heeney, J. L. & Towers, G. J. (2008b). Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J Virol 82, 7243-7247.
132. Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M. & Hope, T. J. (2006). Proteasome inhibitors uncouple rhesus TRIM5a restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A 103, 7465-7470.
133. Yamashita, M. & Emerman, M. (2004). Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J Virol 78, 5670-5678.
134. Yang, H., Ji, X., Zhao, G., Ning, J., Zhao, Q., Aiken, C., Gronenborn, A. M., Zhang, P. & Xiong, Y. (2012). Structural insight into HIV-1 capsid recognition by rhesus TRIM5a. Proc Natl Acad Sci U S A 109, 18372-18377.
135. Yap, M. W. & Stoye, J. P. (2003). Intracellular localisation of Fv1. Virology 307, 76-89.
136. Yap, M. W., Nisole, S., Lynch, C. & Stoye, J. P. (2004). Trim5a protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101, 10786-10791.
137. Yap, M. W., Nisole, S. & Stoye, J. P. (2005). A single amino acid change in the SPRY domain of human Trim5a leads to HIV-1 restriction. Curr Biol 15, 73-78.
138. Yap, M. W., Mortuza, G. B., Taylor, I. A. & Stoye, J. P. (2007). The design of artificial retroviral restriction factors. Virology 365, 302-314.
139. Yap, M. W., Lindemann, D., Stanke, N., Reh, J., Westphal, D., Hanenberg, H., Ohkura, S. & Stoye, J. P. (2008). Restriction of foamy viruses by primate Trim5a. J Virol 82, 5429-5439.
140. Ylinen, L. M., Price, A. J., Rasaiyaah, J., Hué, S., Rose, N. J., Marzetta, F., James, L. C. & Towers, G. J. (2010). Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity. PLoS Pathog 6, e1001062.
141. Zhang, F., Ya, L. T., Iwatani, Y., Higo, K., Suzuki, Y., Tanaka, M., Nakahara, T., Ono, T., Sakai, H. & other authors (2000). Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system. J Virol 74, 6193-6197.
142. Zhao, G., Ke, D., Vu, T., Ahn, J., Shah, V. B., Yang, R., Aiken, C., Charlton, L. M., Gronenborn, A. M. & Zhang, P. (2011). Rhesus TRIM5a disrupts the HIV-1 capsid at the inter-hexamer interfaces. PLoS Pathog 7, e1002009.
143. Zhao, G., Perilla, J. R., Yufenyuy, E. L., Meng, X., Chen, B., Ning, J., Ahn, J., Gronenborn, A. M., Schulten, K. & other authors (2013). Mature HIV-1 capsid structure by cryo-electron microscopy and allatom molecular dynamics. Nature 497, 643-646.
144. Zheng, Y.-H., Jeang, K.-T. & Tokunaga, K. (2012). Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology 9, 112.